Latest News & Earnings

Reddit Pulser/wallstreetbets
Sold NVDA Bought a Lambo

You had the best investment of your life and turned it into the worst investment of your life. You are a true regard.

Selling half a six-year Nvidia position for a car converts an unrealized gain into a taxable one, and 771 comments are debating whether borrowing against the shares would have been cheaper. How you fund a windfall purchase decides what you keep.

Reddit Pulser/personalfinance
Should I max my HSA even if I don’t use most of it on medical expenses?

Yes! I max out my HSA and *never* use it. Saving that money for later in life - when you'll likely have more medical bills - is the best thing you can do.

The thread's advice is unanimous: treat the HSA as the most tax-advantaged retirement account you have, fund it to the max and pay medical bills out of pocket so the balance stays invested. The mistake is spending it down every year and losing decades of untaxed growth.

DATA RELEASE
2-Year Treasury Yield
4.61%
-6 bp

The front end just backed off its highs, with the 2-year slipping 6 basis points to 4.61% after the Fed held rates steady. That is the part of the curve that reprices first when policy expectations shift, so money market and short-duration bond holders feel it immediately.

Source: FRED · DGS2
DATA RELEASE
10-Year Treasury Yield
4.98%
-7 bp

The 10-year slipped back below the 5% line, down 7 basis points to 4.98%, the third straight easing that pulls mortgage rates, bank funding costs and long-duration equity valuations with it.

Source: FRED · DGS10

Sponsored

ORealty Income
Dividend$0.27ex-date 2026-10-30 · 6.18% yield · 26 yrs paying

Twenty-six unbroken years of monthly payouts now come with a 6.18% indicated yield, the kind of entry point net lease buyers rarely get. Miss today's ex-date and you wait another month to start collecting.

VRTXVertex Pharmaceuticals
New 52-week high$558.88+0.2% vs prior high · 2026-09-03

Vertex Pharmaceuticals closed at $558.88, a fresh 52-week high and 0.16% above the September 3 peak. The $141.7 billion biotech has now reclaimed the top of its range after a two-month stretch spent trading closer to $500.

REGNRegeneron
New 52-week high$927.89+8.9% vs prior high · 2026-09-02

Regeneron's Q3 earnings beat lifted it to a fresh 52-week high of $927.89, clearing the September 2 peak by 8.9%. That single jump erases months of range-bound trading in the biotech.